Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorAsan Medical Center

About this trial

This study is a prospective, multicenter study in the real practice to validate the diagnostic performances and clinical impact of coronary angiography \& intravascular ultrasound (IVUS)-based models developed by machine learning (ML).

Eligibility criteria

Qualifiers

Age 19 years or older

Symptomatic angina patients with objective myocardial ischemia

Patients with at least one major epicardial coronary artery that requires stent implantation

Subject who signs with informed consent form

Disqualifiers

ST-segment elevation MI at admission

Patients who underwent coronary artery bypass surgery or heart transplantation

Left ventricular ejection fraction <30%

Cardiogenic shock

Trial design

Treatments tested in this trial

  • percutaneous coronary intervention

Treatment groups

No treatment groups listed

Sponsors and collaborators

Asan Medical Center

Lead sponsor

Boston Scientific Corporation

Collaborator